CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Remon, Jordi, Collazo, Ana, Jimenez, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797323/
https://www.ncbi.nlm.nih.gov/pubmed/35117575
http://dx.doi.org/10.21037/tcr.2020.03.09
_version_ 1784641523120340992
author Remon, Jordi
Collazo, Ana
Jimenez, Beatriz
author_facet Remon, Jordi
Collazo, Ana
Jimenez, Beatriz
author_sort Remon, Jordi
collection PubMed
description
format Online
Article
Text
id pubmed-8797323
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87973232022-02-02 CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer Remon, Jordi Collazo, Ana Jimenez, Beatriz Transl Cancer Res Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC8797323/ /pubmed/35117575 http://dx.doi.org/10.21037/tcr.2020.03.09 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial Commentary
Remon, Jordi
Collazo, Ana
Jimenez, Beatriz
CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
title CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
title_full CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
title_fullStr CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
title_full_unstemmed CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
title_short CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
title_sort checkmate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797323/
https://www.ncbi.nlm.nih.gov/pubmed/35117575
http://dx.doi.org/10.21037/tcr.2020.03.09
work_keys_str_mv AT remonjordi checkmate227trialhasnotcheckedtheimmunestrategyinfirstlinesettinginadvancednonsmallcelllungcancer
AT collazoana checkmate227trialhasnotcheckedtheimmunestrategyinfirstlinesettinginadvancednonsmallcelllungcancer
AT jimenezbeatriz checkmate227trialhasnotcheckedtheimmunestrategyinfirstlinesettinginadvancednonsmallcelllungcancer

Ejemplares similares